IFPMA Code of Practice 2019 – Key Changes
The IFPMA Code of Practice is a living document and has been revised five times over recent decades, ensuring that practices in the biopharmaceutical industry are governed by ethical standards in line with societal expectations.
The new IFPMA Code of Practice will come into effect on 1st January 2019.This video and supporting slide-deck summarizes the key changes between the new IFPMA Code of Practice 2019 and its 2012 predecessor, and discusses certain implications of these revisions for our members.
Downloads
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
